Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Patrys Limited ( (AU:PAB) ) is now available.
Patrys Limited announced a change in the director’s interest, specifically regarding Dr. James Campbell’s holdings. Dr. Campbell’s unlisted options, totaling 23,389,950 and exercisable at $0.059, expired on September 30, 2025. This change does not affect his direct holding of 33,679,803 fully paid ordinary shares or his indirect holding of 2,910,125 fully paid ordinary shares. The expiration of these options may impact the company’s stock option management and director’s equity stake, but it does not alter the overall shareholding structure significantly.
More about Patrys Limited
Patrys Limited operates in the biotechnology industry, focusing on the development of novel antibody therapies for cancer treatment. The company leverages its proprietary technology to create innovative solutions aimed at improving patient outcomes in oncology.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$9.17M
See more insights into PAB stock on TipRanks’ Stock Analysis page.